We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+12.33%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+640.53%
AUM
$15.6B
AUM Growth
+$1.15B
Cap. Flow
-$252M
Cap. Flow %
-1.61%
Top 10 Hldgs %
27.58%
Holding
750
New
44
Increased
354
Reduced
220
Closed
56

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$64.3M
2
AAPL icon
Apple
AAPL
+$53M
3
CRM icon
Salesforce
CRM
+$52.8M
4
AMAT icon
Applied Materials
AMAT
+$42.9M
5
MU icon
Micron Technology
MU
+$41.3M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$68.6M
2
ADBE icon
Adobe
ADBE
+$58.8M
3
ANSS
Ansys
ANSS
+$52.1M
4
TJX icon
TJX Companies
TJX
+$39.6M
5
TMO icon
Thermo Fisher Scientific
TMO
+$38.3M

Sector Composition

Rank Sector Weight
1 Technology 31.73%
2 Healthcare 28.37%
3 Financials 8.73%
4 Consumer Discretionary 8.29%
5 Industrials 6.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LOOP icon
676
Loop Industries
LOOP
$31.7M
– –
-413,327
Closed -$1.56M
NICE icon
677
Nice
NICE
$6.01B
– –
-5,557
Closed -$1.11M
NTLA icon
678
Intellia Therapeutics
NTLA
$1.68B
– –
-91,275
Closed -$2.78M
PHM icon
679
Pultegroup
PHM
$24.8B
– –
-3,206
Closed -$331K
RCI icon
680
Rogers Communications
RCI
$18.7B
– –
-5,375
Closed -$253K
RL icon
681
Ralph Lauren
RL
$24.2B
– –
-2,924
Closed -$422K
RNAM
682
DELISTED
Avidity Biosciences
RNAM
– –
-290,067
Closed -$2.63M
RNR icon
683
RenaissanceRe
RNR
$13.2B
– –
-22,557
Closed -$4.42M
ROKU icon
684
Roku
ROKU
$22.5B
– –
-4,744
Closed -$435K
ECHO
685
EchoStar
ECHO
$25.9B
– –
-244,005
Closed -$4.04M
SLAB icon
686
Silicon Laboratories
SLAB
$7.2B
– –
-176,863
Closed -$23.4M
SSNC icon
687
SS&C Technologies
SSNC
$18.7B
– –
-61,505
Closed -$3.76M
STAG icon
688
STAG Industrial
STAG
$7.09B
– –
-102,375
Closed -$4.02M
TAL icon
689
TAL Education Group
TAL
$6.93B
– –
-2,098,800
Closed -$26.5M
TEX icon
690
Terex
TEX
$7.58B
– –
-276,522
Closed -$15.9M
TWST icon
691
Twist Bioscience
TWST
$7.83B
– –
-71,360
Closed -$2.63M
UDR icon
692
UDR
UDR
$12.1B
– –
-227,412
Closed -$8.71M
URBN icon
693
Urban Outfitters
URBN
$6.81B
– –
-204,001
Closed -$7.28M
VC icon
694
Visteon
VC
$2.8B
– –
-4,576
Closed -$572K
VOYA icon
695
Voya Financial
VOYA
$9.08B
– –
-3,962
Closed -$289K
WPM icon
696
Wheaton Precious Metals
WPM
$60.6B
– –
-9,983
Closed -$495K
XP icon
697
XP
XP
$8.37B
– –
-22,000
Closed -$574K
YUMC icon
698
Yum China
YUMC
$16.5B
– –
-24,000
Closed -$1.02M
ZM icon
699
Zoom
ZM
$31.4B
– –
-9,972
Closed -$717K
ZTO icon
700
ZTO Express
ZTO
$18.2B
– –
-637,100
Closed -$13.6M
25 26 27
28
29

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
NAM
Nissay Asset Management Tokyo, Japan $18.9B AUM 27.21% 1-Year Est. Return

Candriam SCA's Q1 2024 Portfolio in Review

As of Q1 2024, Candriam SCA held 750 positions worth $15.6B, up 7.9% from $14.5B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Candriam SCA's Q1 2024 filing shows 44 new, 354 increased, 220 reduced and 56 closed positions. Its largest new stake was Altair Engineering Inc: 434,749 shares worth $37.5M. The largest sale was Merck, an estimated $68.6M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q1 2024 buy was Altair Engineering Inc: 434,749 shares worth $37.5M.
  • Candriam SCA added most to NVIDIA in Q1 2024, an estimated $64.3M increase.
  • Candriam SCA's biggest Q1 2024 reduction was Merck, cutting an estimated $68.6M.
  • Candriam SCA fully exited Immunogen Inc in Q1 2024, selling an estimated $33.3M.
  • Candriam SCA's ten largest holdings make up 28% of its $15.6B portfolio in Q1 2024.
  • Candriam SCA opened 44 new positions and closed 56 in Q1 2024.
  • Candriam SCA's portfolio value rose 7.9% quarter-over-quarter to $15.6B.

Based on Candriam SCA's 13F filing for Q1 2024, filed 6 May 2024.